1. Nutex is under investigation for potential securities law violations. 2. Allegations involve suspicious billing practices through third-party vendors. 3. Stock prices fell significantly following these revelations. 4. Company delayed quarterly filing due to financial statement issues. 5. Investors are encouraged to contact legal representation for losses.
NUTX's stock price fell by over 26% following damaging allegations about billing fraud. Similar cases in the past have led to long-term negative impacts on stock prices.
The serious nature of the claims and their impact on investor confidence significantly affect NUTX. Legal outcomes may have ripple effects in the healthcare sector.
Legal investigations typically cause immediate stock price declines. Past examples show recovery can be protracted if fraud is confirmed.
Law Offices of Howard G. Smith continues its investigation on behalf of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) investors concerning the Company's possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUTEX HEALTH INC. (NUTX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Happened?
On July 22, 2025, Blue Orca Capital published a report alleging, among other things, that Nutex's share price has "surged" after it "began submitting the majority of its patient bills to the arbitration process for settling out-of-network medical bills . . . using an unidentified ‘third party IDR vendor.'" The report further states that the "mystery consultant" is HaloHD, which, according to multiple lawsuits, has "engag[ed] in a coordinated fraudulent scheme to steal millions of dollars from insurance companies on behalf of and in conjunction with its healthcare billing clients."
On this news, Nutex's stock price fell $11.18, or 10.1%, to close at $100.01 per share on July 22, 2025, thereby injuring investors.
On August 14, 2025, Nutex announced it would delay filing its quarterly financial statements for the period ending June 30, 2025, "due to additional time needed to analyze classification of certain equity instruments and finalize its financial statements."
On this news shares fell $18.22, or 16.4%, to close at $92.91 on August 15, 2025, thereby injuring investors further.
Contact Us To Participate or Learn More:
If you purchased Nutex securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com,
Visit our website at: www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250818052285/en/
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com